An immunosuppressed microenvironment distinguishes lateral ventricle–contacting glioblastomas
Todd Bartkowiak(Vanderbilt University), Jonathan M. Irish(Vanderbilt University), Silky Chotai(Breast Cancer Research Foundation), Justine Sinnaeve(Vanderbilt University), Kyle D. Weaver(Vanderbilt University Medical Center), Nalin Leelatian(Yale University), Caroline E. Roe(Vanderbilt University), Asa A. Brockman(Vanderbilt University), Akshitkumar M. Mistry(University of Louisville), Reid C. Thompson(Neurological Surgery), Lola B. Chambless(Vanderbilt University), Bret C. Mobley(Vanderbilt University Medical Center), Rebecca A. Ihrie(Vanderbilt University), Sierra M. Lima(Vanderbilt University), Madeline Hayes(Vanderbilt University)
Cited by 10
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|580
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540